Table of Contents

December 01, 2018; Volume 85, Issue 12
  • From the Editor

  • The Clinical Picture

      • Lung complications of prescription drug abuse

        Josiah D. McCain, MD, Monia E. Werlang, MD, Andras Khoor, MD, PhD and Isabel Mira-Avendano, MD
        • Cleveland Clinic Journal of Medicine December 2018, 85 (12) 910-911;
        • DOI: https://doi.org/10.3949/ccjm.85a.18050
        • Opioid tablets crushed, then injected intravenously.

      • Acute necrotizing esophagitis

        Takeshi Kondo, MD
        • Cleveland Clinic Journal of Medicine December 2018, 85 (12) 912-913;
        • DOI: https://doi.org/10.3949/ccjm.85a.18054
        • Poorly controlled diabetes, confusion, coffee-ground emesis.

  • 1-Minute Consult

      • What can I do when first-line measures are not enough for vasovagal syncope?

        Erika Hutt-Centeno, MD and Kenneth A. Mayuga, MD, FHRS, FACC, FACP
        • Cleveland Clinic Journal of Medicine December 2018, 85 (12) 920-922;
        • DOI: https://doi.org/10.3949/ccjm.85a.17112
        • Second-line measures include midodrine, fludrocortisone, beta-blockers, and SSRIs, but evidence is limited.

      • Are anti-TNF drugs safe for pregnant women with inflammatory bowel disease?

        Gregory T. Brennan, MD, Alex Duong, Emily T. Nguyen, PharmD and Douglas L. Nguyen, MD
        • Cleveland Clinic Journal of Medicine December 2018, 85 (12) 923-924;
        • DOI: https://doi.org/10.3949/ccjm.85a.18037
        • Active IBD poses a greater risk than continuing drug therapy.

      • Do all hospital inpatients need cardiac telemetry?

        Motaz Baibars, MD, Yasser Al-Khadra, MD, Zaher Fanari, MD, Homam Moussa Pacha, MD, Mohamad Soud, MD and M. Chadi Alraies, MD
        • Cleveland Clinic Journal of Medicine December 2018, 85 (12) 925-927;
        • DOI: https://doi.org/10.3949/ccjm.85a.17114
        • Routine cardiac telemetry raises costs and does little.

  • Medical Grand Rounds

  • Review

  • Opinion

      • Telemedicine: Past, present, and future

        Jamal H. Mahar, MD, Gregory J. Rosencrance, MD and Peter A. Rasmussen, MD
        • Cleveland Clinic Journal of Medicine December 2018, 85 (12) 938-942;
        • DOI: https://doi.org/10.3949/ccjm.85a.17062
        • Low reimbursement, licensing, practice issues limit its use.

      • Cannabis for chronic pain: Not a simple solution

        Xavier F. Jimenez, MD
        • Cleveland Clinic Journal of Medicine December 2018, 85 (12) 950-952;
        • DOI: https://doi.org/10.3949/ccjm.85a.18089
        • Real concerns include amotivation, worsening psychiatric states, chronic disability, and chemical dependence.

  • Departments

      • Prostate cancer screening, November 2018

        David L. Keller, MD, FACP
        • Cleveland Clinic Journal of Medicine December 2018, 85 (12) 908;
        • DOI: https://doi.org/10.3949/ccjm.85c.12001
        • A reader comments on the use of prostate-specific antigen (November 2018).

      • Men’s health 2018 (November 2018)

        • Cleveland Clinic Journal of Medicine December 2018, 85 (12) 913;
        • An error occurred in Chaitoff A, Killeen TC, Nielsen C. Men’s health 2018: BPH, prostate cancer, erectile dysfunction, supplements. Cleve Clin J Med 2018; 85(11):871–880. doi:10.3949/ccjm.85a.18011.